Acelrx Pharmaceuticals Inc
NASDAQ:ACRX 10:44:42 AM EDT
| Market Cap (Intraday) | 91.75M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.68 |
| 50-Day MA | $0.89 |
| 200-Day MA | $1.26 |
Acelrx Pharmaceuticals Inc Stock, NASDAQ:ACRX
25821 Industrial Boulevard, Suite 400, Hayward, California 94545
United States of America
Phone: +1.650.216.3500
Number of Employees: 54
Description
AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies use in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in Redwood City, CA.